Literature DB >> 9206972

Immune response of neonates elicited by somatic transgene vaccination with naked DNA.

A Bot1, S Antohi, C Bona.   

Abstract

Neonates display lower immune responsiveness and higher susceptibility for high-dose tolerance. Quantitative as well as functional differences between the neonatal and adult lymphocytes or antigen presenting cells (APC) respectively, explain the particular immune responsiveness during the early stages of the postnatal development. Reduced numbers of lymphocytes and APCs as well as a modified responsiveness of T cells in neonates, are the main factors that account for the low threshold of tolerance in newborns. Taking into account these particularities, the design of effective vaccines for neonates poses significant difficulties. We hypothesized that a continuous exposure to low doses of antigens may avoid high-zone tolerance and may lead instead, to effective expansion of effector and memory cells. Indeed, inoculation of newborn mice with plasmids encoding nucleoprotein (NP) or hemagglutinin (HA) of influenza virus, led to the priming of specific cytotoxic (CTL), helper (Th) and B cells, rather than induction of unresponsiveness. Mice immunized as neonates with naked DNA and challenged later with lethal doses of influenza virus, displayed significant protection. Thus, DNA immunization may be a promising strategy for vaccination against serious infectious diseases of infants and children.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9206972     DOI: 10.2741/a181

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  6 in total

1.  CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

Authors:  C L Brazolot Millan; R Weeratna; A M Krieg; C A Siegrist; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

Authors:  Shixia Wang; Chris Parker; Jessica Taaffe; Alicia Solórzano; Adolfo García-Sastre; Shan Lu
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

Review 3.  T cell immunity in neonates.

Authors:  A M Garcia; S A Fadel; S Cao; M Sarzotti
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

4.  Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus.

Authors:  Heng Ding; Cheguo Tsai; Ramona Alikiiteaga Gutiérrez; Fan Zhou; Philippe Buchy; Vincent Deubel; Paul Zhou
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

5.  Priming with a DNA vaccine and boosting with an inactivated vaccine enhance the immune response against infectious bronchitis virus.

Authors:  Zicheng Guo; Hongning Wang; Tai Yang; Xue Wang; Dan Lu; Yulin Li; Yi Zhang
Journal:  J Virol Methods       Date:  2010-03-20       Impact factor: 2.014

Review 6.  Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy.

Authors:  Michal Schwartz; Oleg Butovsky; Jonathan Kipnis
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.